Dizal (Jiangsu) Pharmaceutical Co (SHSE:688192) Operating Cash Flow per Share : ¥-1.58 (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Dizal (Jiangsu) Pharmaceutical Co Operating Cash Flow per Share?

Dizal (Jiangsu) Pharmaceutical Co's operating cash flow per share for the three months ended in Mar. 2025 was ¥-0.32. Dizal (Jiangsu) Pharmaceutical Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-1.58.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Dizal (Jiangsu) Pharmaceutical Co's Operating Cash Flow per Share or its related term are showing as below:

SHSE:688192' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -27.8 Med: -16.25 Max: -4.7
Current: -4.7

During the past 7 years, Dizal (Jiangsu) Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was -4.70% per year. The lowest was -27.80% per year. And the median was -16.25% per year.

SHSE:688192's 3-Year OCF Growth Rate is ranked worse than
68.59% of 780 companies
in the Drug Manufacturers industry
Industry Median: 8.85 vs SHSE:688192: -4.70

Dizal (Jiangsu) Pharmaceutical Co Operating Cash Flow per Share Historical Data

The historical data trend for Dizal (Jiangsu) Pharmaceutical Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dizal (Jiangsu) Pharmaceutical Co Operating Cash Flow per Share Chart

Dizal (Jiangsu) Pharmaceutical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-1.14

-1.37

-1.49

-2.38

-1.57

Dizal (Jiangsu) Pharmaceutical Co Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.30	-0.42	-0.40	-0.45	-0.32

Competitive Comparison of Dizal (Jiangsu) Pharmaceutical Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Dizal (Jiangsu) Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dizal (Jiangsu) Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dizal (Jiangsu) Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Dizal (Jiangsu) Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Dizal (Jiangsu) Pharmaceutical Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Dizal (Jiangsu) Pharmaceutical Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-650.525	/	414.684
	=	-1.57

Dizal (Jiangsu) Pharmaceutical Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-131.667	/	418.507
	=	-0.31

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1.58

Dizal (Jiangsu) Pharmaceutical Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Dizal (Jiangsu) Pharmaceutical Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Dizal (Jiangsu) Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

Jinghui East Road, Room 4105, Building E (Building 5), Huirong Business Plaza, Xinwu District, Jiangsu Province, Wuxi City, CHN, 201203

Website

http://www.dizalpharma.com

Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.

Executives

	Directors, senior managers, core technical personn
Qiao Wei Jun	Core technical personnel
Wu Qing Yi	senior management
Lv Hong Bin	senior management
	Directors, senior managers
	Senior management, core technical personnel
Zheng Li	Core technical personnel
Yang Zhen Fan	Senior management, core technical personnel
	Senior management, core technical personnel
Chen Kan	Core technical personnel
Chen Su Qin	Senior management, core technical personnel
Zhang Zhi Wei	senior management
	Senior management, core technical personnel
	Senior management, core technical personnel

Dizal (Jiangsu) Pharmaceutical Co Headlines

No Headlines